Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Suchitra Rao

Showing results (111-120 of 143) with videos related to

Pageof 15
Sort By:
The Journal of Infectious Diseases|January 23, 2023
Vaccine Effectiveness Against Influenza-Associated Urgent Care, Emergency Department, and Hospital Encounters During the 2021-2022 Season, VISION NetworkMark W Tenforde, Zachary A Weber, Malini B DeSilva, et al.
JAMA Network Open|September 26, 2022
Estimation of COVID-19 mRNA Vaccine Effectiveness Against Medically Attended COVID-19 in Pregnancy During Periods of Delta and Omicron Variant Predominance in the United StatesStephanie J Schrag, Jennifer R Verani, Brian E Dixon, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|November 14, 2023
Symptoms, Viral Loads, and Rebound Among COVID-19 Outpatients Treated With Nirmatrelvir/Ritonavir Compared With Propensity Score-Matched Untreated IndividualsSarah E Smith-Jeffcoat, Jessica E Biddle, H Keipp Talbot, et al.
MMWR. Morbidity and Mortality Weekly Report|August 17, 2023
Effectiveness of Monovalent and Bivalent mRNA Vaccines in Preventing COVID-19-Associated Emergency Department and Urgent Care Encounters Among Children Aged 6 Months-5 Years - VISION Network, United States, July 2022-June 2023Ruth Link-Gelles, Allison Avrich Ciesla, Elizabeth A K Rowley, et al.
MMWR. Morbidity and Mortality Weekly Report|March 28, 2024
Interim Effectiveness of Updated 2023-2024 (Monovalent XBB.1.5) COVID-19 Vaccines Against COVID-19-Associated Hospitalization Among Adults Aged ≥18 Years with Immunocompromising Conditions - VISION Network, September 2023-February 2024Ruth Link-Gelles, Elizabeth A K Rowley, Malini B DeSilva, et al.
BMJ (Clinical Research Ed.)|October 3, 2022
Waning of vaccine effectiveness against moderate and severe covid-19 among adults in the US from the VISION network: test negative, case-control studyJill M Ferdinands, Suchitra Rao, Brian E Dixon, et al.
MMWR. Morbidity and Mortality Weekly Report|December 29, 2022
Early Estimates of Bivalent mRNA Vaccine Effectiveness in Preventing COVID-19-Associated Emergency Department or Urgent Care Encounters and Hospitalizations Among Immunocompetent Adults - VISION Network, Nine States, September-November 2022Mark W Tenforde, Zachary A Weber, Karthik Natarajan, et al.
Lancet (London, England)|October 19, 2024
Respiratory syncytial virus (RSV) vaccine effectiveness against RSV-associated hospitalisations and emergency department encounters among adults aged 60 years and older in the USA, October, 2023, to March, 2024: a test-negative design analysisAmanda B Payne, Janet A Watts, Patrick K Mitchell, et al.
Influenza and Other Respiratory Viruses|March 17, 2024
Risk of COVID-19 Hospitalization and Protection Associated With mRNA Vaccination Among US Adults With Psychiatric DisordersMatthew E Levy, Duck-Hye Yang, Margaret M Dunne, et al.
The Journal of Infectious Diseases|November 23, 2022
Protection of Two and Three mRNA Vaccine Doses Against Severe Outcomes Among Adults Hospitalized With COVID-19-VISION Network, August 2021 to March 2022Malini B DeSilva, Patrick K Mitchell, Nicola P Klein, et al.
Pageof 15

Showing results (111-120 of 143) with videos related to

Sort By:
Pageof 15
The Journal of Infectious Diseases|January 23, 2023
Vaccine Effectiveness Against Influenza-Associated Urgent Care, Emergency Department, and Hospital Encounters During the 2021-2022 Season, VISION NetworkMark W Tenforde, Zachary A Weber, Malini B DeSilva, et al.
JAMA Network Open|September 26, 2022
Estimation of COVID-19 mRNA Vaccine Effectiveness Against Medically Attended COVID-19 in Pregnancy During Periods of Delta and Omicron Variant Predominance in the United StatesStephanie J Schrag, Jennifer R Verani, Brian E Dixon, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|November 14, 2023
Symptoms, Viral Loads, and Rebound Among COVID-19 Outpatients Treated With Nirmatrelvir/Ritonavir Compared With Propensity Score-Matched Untreated IndividualsSarah E Smith-Jeffcoat, Jessica E Biddle, H Keipp Talbot, et al.
MMWR. Morbidity and Mortality Weekly Report|August 17, 2023
Effectiveness of Monovalent and Bivalent mRNA Vaccines in Preventing COVID-19-Associated Emergency Department and Urgent Care Encounters Among Children Aged 6 Months-5 Years - VISION Network, United States, July 2022-June 2023Ruth Link-Gelles, Allison Avrich Ciesla, Elizabeth A K Rowley, et al.
MMWR. Morbidity and Mortality Weekly Report|March 28, 2024
Interim Effectiveness of Updated 2023-2024 (Monovalent XBB.1.5) COVID-19 Vaccines Against COVID-19-Associated Hospitalization Among Adults Aged ≥18 Years with Immunocompromising Conditions - VISION Network, September 2023-February 2024Ruth Link-Gelles, Elizabeth A K Rowley, Malini B DeSilva, et al.
BMJ (Clinical Research Ed.)|October 3, 2022
Waning of vaccine effectiveness against moderate and severe covid-19 among adults in the US from the VISION network: test negative, case-control studyJill M Ferdinands, Suchitra Rao, Brian E Dixon, et al.
MMWR. Morbidity and Mortality Weekly Report|December 29, 2022
Early Estimates of Bivalent mRNA Vaccine Effectiveness in Preventing COVID-19-Associated Emergency Department or Urgent Care Encounters and Hospitalizations Among Immunocompetent Adults - VISION Network, Nine States, September-November 2022Mark W Tenforde, Zachary A Weber, Karthik Natarajan, et al.
Lancet (London, England)|October 19, 2024
Respiratory syncytial virus (RSV) vaccine effectiveness against RSV-associated hospitalisations and emergency department encounters among adults aged 60 years and older in the USA, October, 2023, to March, 2024: a test-negative design analysisAmanda B Payne, Janet A Watts, Patrick K Mitchell, et al.
Influenza and Other Respiratory Viruses|March 17, 2024
Risk of COVID-19 Hospitalization and Protection Associated With mRNA Vaccination Among US Adults With Psychiatric DisordersMatthew E Levy, Duck-Hye Yang, Margaret M Dunne, et al.
The Journal of Infectious Diseases|November 23, 2022
Protection of Two and Three mRNA Vaccine Doses Against Severe Outcomes Among Adults Hospitalized With COVID-19-VISION Network, August 2021 to March 2022Malini B DeSilva, Patrick K Mitchell, Nicola P Klein, et al.
Pageof 15